32. Shor R, Halabe A, Rishver S et al. Severe hypophosphatemia in sepsis as a mortality predictor. Correspondence and offprint requests to: Katrin Mehler; E-mail: katrin.mehler@uk-koeln.de *These authors contributed equally to this work Abstract Background. Renal oligohydramnion (ROH) is predominantly caused by congenital abnormalities of the kidney and urogenital tract (CAKUT). Although the number of neonates born with chronic renal failure is small, they provide many challenges, and among the most problematic are respiratory management and long-term treatment of chronic renal failure. We studied the value of prenatal and perinatal variables to predict survival and the general long-term outcome of our ROH population. Method. A single-centre retrospective chart review was conducted in 36 neonates with ROH treated between 1996 and 2007. Respiratory data sets including minimum inspiratory oxygen concentration (FiO 2 , 1d), best oxygenation index (BOI, 1d) and minimum arterial partial carbon dioxide (pCO 2 , 1d) at the first day of life were available in 23 children requiring intubation.
Introduction
Before the 1970s, performing renal replacement therapy (RRT) in children with end-stage renal failure (ESRF) was mostly paediatric unethical. As a result of the progress in paediatric intensive care medicine, proven favourable long-term outcome as well as adaptations of RRT techniques to paediatric needs, dialysis and subsequent transplantation is offered to most children today [1] [2] [3] [4] [5] [6] .
Congenital abnormalities of the kidney and urogenital tract (CAKUT) are frequently detected antenatally iñ 1% of children [7] . Bilateral disease that results in renal oligohydramnion (ROH) indicates relevant renal function impairment and implies a substantial risk both for renal dysfunction and for pulmonary complications (hypoplasia). Next to structural abnormalities of the vast CAKUT spectrum, autosomal recessive polycystic kidney disease (ARPKD), bilateral renal venous thrombosis, cortical necrosis and many more conditions may present with ROH on fetal ultrasound scans [7] [8] [9] .
There are conflicting data on the prognostic impact of ROH and the consequences of prenatal diagnosis. In older series, prognosis was mostly regarded as poor and all or most children with CAKUT and ROH died [10] [11] [12] . Other series report more encouraging survival rates. This is especially true for cases where fetal lung development is not or only mildly affected [9, [13] [14] [15] [16] . One would expect that the wide usage of antenatal fetal ultrasound will lead to more terminations for potentially lethal renal anomalies resulting in declining numbers of patients with ROH. Not surprisingly terminations seem to be frequent practice in some institutions [17] .
Others report the opposite situation with parents demanding all available treatment and not opting for pregnancy termination or postpartal palliative care [4] .
Despite the enormous progress made in paediatric intensive care and the wide availability of modern ventilation techniques, respiratory stabilization is still a challenge in some babies with ROH and lung hypoplasia. Pulmonary hypoplasia is believed to originate directly from impaired development and maturation of pulmonary azini. In a series of 850 perinatal autopsies, lung hypoplasia was most common found in association with renal agenesis followed by diaphragmatic hernia [18] [19] [20] .
The main aim of our study was to investigate the value of pre-and postnatal paediatric variables with special focus on the early respiratory and general survival in our ROH cohort.
Materials and methods

Study population
This study is a single-centre retrospective analysis of infants with antenatally diagnosed ROH treated at our institution from October 1996 to October 2007. Our hospital provides a Level III B neonatal intensive care unit (NICU) and is the primary regional centre for paediatric RRT.
A total of 36 live-born infants (30 males and 6 females) with ROH were analysed using retrospective chart review. Thirty-one babies were born at the University of Cologne Medical Centre and five were outborn neonates transferred for further respiratory and renal management. Individual patient characteristics are given in Table 1 .
Definition of ROH was generalized reduction in amniotic fluid with two diameter pocket being <15 cm 2 in the presence of kidney and/or urogenital tract abnormalities [21] . All ultrasound investigations were performed by licensed sonographers being certified by the German Ultrasound Society for extensive experience in prenatal ultrasound (Deutsche Gesellschaft für Ultraschall in der Medizin e.V. Level III).
Causes of renal disease were as follows: most children suffered from CAKUT. Nineteen neonates had obstructive uropathy, among them 18 boys with posterior urethral valves (PUV) and 1 girl with urethral atresia and cloacal malformation. Two out of the 18 boys had prune belly syndrome (PBS) with associated comorbidities. The renal dysplasia/agenesia group (n ¼ 10) included two infants with bilateral renal agenesis, six babies with bilateral renal dysplasia and two children with unilateral renal agenesis plus contralateral multicystic dysplastic. In addition, six infants suffered from polycystic kidney disease (five ARPKD and one autosomal dominant polycystic kidney disease) and a single child from fetal bilateral renal vein thrombosis. The diagnosis of ARPKD (next to having the characteristic clinical features) was indirectly established by showing linkage to the PKHD1 locus in all five cases. Pre-and postnatal counselling was provided to all families (including outborn infants) by a team of senior paediatric nephrologists and neonatologists.
Ventilatory management. Mechanical ventilation was performed pressure controlled with a positive end expiratory preasure of 6-8 cm H 2 O and peak inspiratory pressure (PIP) 20-25 cm H 2 O. Frequency was set at 40-50/min. Bovine surfactant (100 mg/kg) was applied if an inspiratory fraction of oxygen of >0.4 was needed to establish an arterial pO 2 of >50 mmHg. Patients were switched to high-frequency oscillation (HFOV) if oxygenation or ventilation was still poor under conventional ventilation (maximum PIP 28-30 cm H 2 O) to keep arterial pO 2 >50 mmHg, arterial pCO 2 <60 mmHg and pH >7.30. SensorMedics 3100A respirator (infants >3000 g) and Babylog 800 plus respirator (infants <3000 g) were used to apply HFOV. Infants were switched from HFOV to conventional ventilation if the mean airway pressure could be reduced <10 cm H 2 O. Inhalative nitric oxide (iNO) (maximum dosage 20 p.p.m.) was applied if oxygenation did not improve or pulmonary hypertension was diagnosed by echocardiography.
Cardiovascular management. Normal saline or full electrolyte fluid flushes were given in order to keep the mean arterial blood pressure >40 mmHg in term and 35 mmHg in preterm infants. Vasopressor therapy was started with dopamine (DP) 3-8 lg/kg/min and dobutamine (DB) 5-10 lg/kg/min. If necessary, norepinephrine (ne) (0.1-1 lg/kg/min) and eventually epinephrine (e) (0.1-1 lg/kg/min) were added.
Data collection
Clinical information collected on each patient included gender, gestational age, birth weight, gestational week in which ROH was first noted, prenatal interventions, renal disease, extrarenal disease, respiratory outcome, presence of lung hypoplasia and pneumothorax on chest X-ray, ventilatory mode, time on mechanical ventilation, the use of nitric oxide and surfactant, renal outcome, timing and duration on RRT and vasopressor support.
On all inborn babies, blood gas and ventilatory data at the first day of life were analysed if infants required mechanical ventilation. The two neonates, whose parents opted not in favour of mechanical ventilation and therefore received only palliative care (n ¼ 2), were excluded from further respiratory analysis. Arterial postductal blood sampling for gas analysis was performed at least every 4 h and minimum PaCO 2 , best oxygenation index (BOI, d1) and minimum fractional inspired O 2 (FiO 2 ) within the first 24 h were determined from a series of blood gases. BOI was calculated from the best blood gas on Day 1 of life as [fractional inspired O 2 (in %) 3 mean airway pressure (in mbar)/PaO 2 (in mmHg)] [22] .
The primary outcome was patient survival until time of hospital discharge. Prenatal (i.e. timepoint of ROH diagnosis, interventions, renal diagnosis) and postnatal parameters (i.e. birth weight, respiratory variables) were determined for their usefulness predicting early (respiratory) survival and late (survival to leave hospital) survival in ROH.
Statistical analysis
All parameters were characterized by descriptive statistics. Differences between survivors and non-survivors were evaluated using independent samples t-tests for continuous and chi-square tests for categorical data. For survival analysis, Kaplan-Meier curves were plotted and compared with the log-rank test. Logistic regression was employed to assess the impact of parameters on survival, expressed as odds ratio (OR) with 95% confidence interval (CI). A P-value <0.05 was considered to be statistically significant. The binary logistic regression model is a multivariate analysis accounting for the problem of multiple factors analysed on a P ¼ 0.05 level. All computations were done using SPSS 17.0 software.
Results
A total of 36 neonates (30 males and 6 females) with ROH were treated during the study period. This number represents the complete set of ROH patients at our institution during the 11-year time span. Overt male predominance can be attributed to the large group of obstructive uropathies in this cohort. The number of pregnancy termination for ROH over that time period remains unknown to us. Table 1 gives individual clinical data and the number of live-born infants treated with ROH by year of birth.
All patients were admitted to the NICU for at least 24 h. Overall hospital mortality of the ROH population was 36% (13 of 36) with the majority of deaths occurring in the neonatal period (11 of 13, 85%). Figure 1 gives representation of survival in patients with ROH. Of the 11 patients who died in the neonatal period, 7 died due to respiratory failure within the first 48 h of life and initiation of dialysis therapy was attempted in none. Two patients died on Day 1 because intubation was withheld and palliative care was initiated (Table 1 ; Patients 30 and 31). The remaining two patients died primarily from renal failure on Days 5 and 6. Given the severity of the underlying renal disorder plus rather low birth weights, parents and physicians mutually agreed on withholding dialysis in these infants (Table 1; Patients 11 and 20).
Two patients died beyond the neonatal period but before discharge on Day 45 (Table 1 ; Patient 26) and on Day 61 (Table 1 ; Patient 3). The first patient with PBS and small bowel stenosis died from (procedure-related) intestinal perforation. The second patient experienced bacterial peritonitis as a complication and died after temporary haemodiafiltration (continuous venovenous hemofiltration).
Looking at the group of underlying renal condition, the renal agenesis/dysplasia cohort showed the worst (30%) and the obstructive uropathies the best survival rates (84%), placing the smaller polycystic kidney disease group right in the middle. Survival analysis (Figure 2) suggests that non-survival may be associated with the type of primary renal diagnosis, although the log-rank test did not reach statistical significance (P ¼ 0.167). This is most likely due to the small number of patients. Logistic regression analysis showed borderline significance for survival being dependent on diagnosis (OR: 5, 95% CI: 1.1-23.1; P ¼ 0.039). Table 2 illustrates the association of prenatal and postnatal variables with survival until discharge. Non-survivors had significantly lower birth weight, earlier detection of ROH and more frequently a diagnosis classified as agenesis/dysplasia. Gender, gestational age, antenatal interventions (amnioinfusions and vesicoamniotic shunting), mechanical ventilation, duration of ventilation and presence of lung hypoplasia and pneumothorax did not reach significance.
For the early respiratory survival (first 24 h of life), data are shown in Table 3 . In this analysis, only children that needed intubation and mechanical ventilation were included. Twenty-three of the 36 infants (66%) required mechanical ventilation for a median duration of 5 days (range 1-40 days). Three children needed only nasal continuous positive airway pressure for the first 24 h. Detailed respiratory data are shown in Table 3 including use of surfactant and iNO.
Minimum FiO 2 , minimum pCO 2 and the best OI within 24 h of life showed significantly different values in survivors and non-survivors (see Table 3 and Figure 3 ). In patients who survived, normocapnia could be achieved within 24 h and FiO 2 could be reduced <0.4. All patients who survived beyond 24 h had a BOI of 9.6 compared to BOI values >24 in the group of non-survivors. Initial onset of ROH indicated borderline significance in predicting survival >24 h in ventilated infants (P ¼ 0.049).
Logistic regression analysis showed that a BOI <9.6 increased chance of survival almost 16-fold (95% CI: 1.4-174.2), while onset of ROH beyond 28 weeks of gestation increased chance of survival 50-fold (95% CI: 4.5-551.4). Using both BOI (</!9.6) and onset of ROH ( />28 weeks) as independent variables, logistic regression analysis allowed the most accurate prediction of survival until discharge with ORs of 30 [BOI (</!9.6), 95% CI: 1.4-647. 4 Table 1 ) of life, respectively, from complications (viral infection and complex syndromal disorder) unrelated to dialysis treatment. Altogether, four children received successful renal grafts at a median age of 25 months (range 23-52 months) including two children that required neonatal PD. In three patients from the neonatal PD group, need for dialysis was temporary and PD could be stopped after 1, 4 and 5 months, respectively. All three are currently managed conservatively, despite marked renal insufficiency and await cadaveric kidney transplantation. One child from the chronic kidney disease (CKD) group underwent pre-emptive living-related renal transplantation at the age of 4.4 years. From the remaining 14 children, renal function recovered to estimated glomerular filtration rate (GFR) within normal limits in 5 children. In the other nine children, CKD did not deteriorate to ESRD so far. From the eight infants presenting with extrarenal and/or complex chromosomal anomalies surviving until discharge, six are still alive including two children that underwent successful kidney transplantation.
Overall survival of our ROH series is 58% (21/36) after a median follow-up time of 96 months (range 30-152 months). Neurological outcome was only grossly assessed, 15 children showed normal or slightly impaired psychomotor skills, while 6 children developed moderate to severe psychomotor retardation.
Discussion
Our overall survival with antenatally diagnosed ROH is 60%. There are centres reporting higher survival rates of Respiratory and general outcome in neonates up to 90% [13, 15] and others mainly older series [11, 12] experiencing much poorer outcome, but some of the latter compromise in part post-mortem data. Our series conducted over a comparable time period comes close to the findings of Klaassen et al. reporting encouraging outcome and long-term survival of~70% [9] . Reasons for the diverse findings are manifold: first and foremost composition of the ROH cohort with regard to the type of underlying renal disease. Presence of extrarenal comorbidities is likely to worsen prognosis; however, some of these children can be treated (but not cured) and benefit from RRT (including transplant), as can be seen in our and other series. The attitude toward providing dialysis therapy to neonates is still a matter of dispute, even among paediatric nephrologists [1] . Carey et al. [6] were able to demonstrate that initiation of dialysis in the neonatal period is not per se a negative predictor. This finding could be reconfirmed in a study from Hannover where infants with congenital kidney disease demonstrated favourable outcome on RRT comparable to older children with survival rates of 75% after a mean follow-up of 2.9 years. [23] . Three of the four babies from our series in whom dialysis was withheld perhaps would receive active treatment today. If patients survive, the neonatal period residual renal function allows conservative treatment in a good proportion of patients [8, 24] . In our own series, in three of eight children, GFR stabilized over time permitting permanent discontinuation of dialysis therapy.
Last but not least, the availability of a multidisciplinary team and local modalities of respiratory support and RRT may influence decision making profoundly. Prenatal interventions like vesicoamniotic shunting had no impact on respiratory survival and survival until discharge in our analysis. The usefulness of those interventions is still a matter of debate but may affect parental reasoning [7, 9] .
Clinical presentation of ROH may range from mild respiratory and renal problems to frank respiratory failure complicated by anuria and ESRF. What makes the situation in ROH quite complicated is that the renal problem and the lung development are inextricably interconnected. After 15 weeks of gestation, amniotic fluid is predominantly produced by the fetal kidneys and oligo-or anhydramnios is suspicious of kidney dysfunction. Fetal lung liquid balance and fetal breathing are considered by far the most important factors needed for normal lung development [18, 19, 25] . Amniotic fluid (AF) production is a dynamic process requiring repeated investigations. As a rule of thumb, the earlier the detection of severe reduction in amniotic fluid, the more likely is critical pulmonary hypoplasia, and the early detection of oligohydramnios has long been regarded as an indicator of poor outcome [26] .
In a recent ROH series, Klaassen et al. [7] found that non-survivors had a significantly earlier diagnosis of ROH than survivors. Using the diagnostic median of 30 weeks as cut-off, diagnosis of ROH prior to this was associated with a higher overall mortality. These data are supported by our study. Logistic regression analysis demonstrated that the risk of non-survival until discharge was increased 75-fold if ROH was diagnosed <28 weeks. In our small series, onset of ROH seems to be the best prenatal prognostic parameter to predict survival. Unfortunately, determining exact onset of ROH is somewhat problematic for obvious reasons. With detection of ROH in the third trimester, we usually do not know whether it was present before and if things have changed for the better or worse [9] .
Lung growth and development are also controlled by a complex interplay of various hormonal, transcriptional and growth factors. In a transgenic model of murine renal dysgenesis. Smith et al. recently demonstrated that abnormal lung growth is preceded by oligohydramnios [19, 27] . This observation led them to propose the existence of a 'renal growth factor' required for adequate pulmonary development in the early embryogenesis. The distant organ effect of kidney failure to the lung has recently regained much interest in the critically ill patient under the new term kidney lung crosstalk [28, 29] . It could be hypothesized that genetic factors, growth factors and imbalance of immune/ inflammatory mediators independently contribute to the Data presented as mean 6 SD or n (%). GA, gestational age; OU, obstructive uropathy; RA/KD, renal agenesis/kidney dysplasia. clinical heterogeneity of ROH. This would explain that although onset (and severity) of ROH can help predict the postnatal pulmonary course in most patients, there are some who despite early diagnosis do well and vice versa [7] . In our study, Patient no. 12 survived with normal renal function, even though ROH was diagnosed before 28 weeks, while Patient no. 5 showed ROH in Week 32 died within 24 h because respiratory stabilization was impossible. For this reason, other prognostic parameters need to be evaluated. Prenatal assessment of lung volume has been more extensively studied in congenital diaphragmatic hernia (CDH) and claimed to be highly reliable predictor by some groups and of no use by others [30] [31] [32] . Thus, prenatal assessment of lung or AF volume may give additive information but certainly can never provide complete prognostic information (e.g. pulmonary hypertension) in ROH. In our own series, retrospective analysis of postnatal chest radiographs for lung hypoplasia did correlate poorly with early respiratory survival.
Despite some analogy to the pulmonary situation in CDH, especially in the cases where an abnormally large kidney (e.g. ARPKD) causes additional diaphragmatic compression, surprisingly little clinical data regarding respiratory outcome and management can be found in the ROH literature. If data are available, it usually describes the proportion of infants in need of ventilatory support and their complications [7, 9] . Interestingly, none of the series has tried to re-evaluate any of the prognostic markers identified in CDH series [32, 33] . Our study is one of the few that gives clinical data on the pulmonary outcome in ROH. In addition to that we have attempted to assess the usefulness of the best oxygenation index (BOI) on the first day of life (1d), a predictive variable of survival in CDH in particular and in the evaluation of the need for extracorporeal membrane oxygenation in general, in the ROH setting. We found that BOI (1d) was the best postnatal prognostic parameter for prediction of the early respiratory and overall survival. BOI discriminated perfectly between survivors and non-survivors. If a BOI <10 could be achieved, no patient died from respiratory failure on the first day of life. If BOI values persisted >10, outcome was fatal within 24 h. This fact and the small sample size led to a broad range of the OR. Interestingly, our findings match well with the analysis of Sinha et al., who recently published their data on prognostic indices in CDH. They identified an almost similar BOI(1d) of >11 to be the best postnatal predictor of nonsurvival [32] . Using logistic regression analysis for a number of potential predictors, only BOI (1d) retained significance. FiO 2 and pCO 2 also provide information, but there are limitations to both parameters (FiO 2 ceiled to 1.0; pCO 2 compromised if permissive hypercapnia is attempted) that make the composite parameter BOI probably the most robust one. Moreover, this parameter is well established in a number of lung diseases like congenital diaphragmatic hernia and meconium aspiration syndrome relevant to neonates. This retrospective analysis has many limitations. A comparatively small number of subjects with a wide spectrum of underlying renal disorders had been studied over a long period of time. To the best of our knowledge, there had been little changes in clinical practice regarding respiratory, cardiovascular and RRT management over the study period. A paediatric peritoneal dialysis programme has been established since the early 1980s at our institution. Use of modern ventilators, surfactant, iNO and HFOV were disposable to all patients throughout the study period. The latter three variables were not significantly associated with survival in our cohort. However, retrospective studies are unable to control for subtle changes in clinical practice and unforeseen confounders.
In conclusion, BOI (1d) seems to be an available simple predictor, which can be routinely calculated. Onset of ROH />28 weeks may be the best predictor for survival but exact information about onset of ROH is frequently impossible to obtain for various reasons. Our finding certainly warrants reconfirmation in larger prospective studies where standardized protocols will allow reliable assessment of potential prenatal and perinatal predictors of outcome in ROH.
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